Cancerguard Multi-Cancer Early Detection Test

Transform the future of cancer screening with the Cancerguard™ test

One simple blood draw can help you detect cancer earlier and impact more lives.

For adults 50-84, with no cancer in the last 3 years
Helps detect cancer types behind at least 80% of diagnoses
Helps detect aggressive cancers, including 6 of the most deadly
689, HSA/FSA eligible

~70% of annual cancer cases and deaths have no recommended screening

With ~600,000 deaths in the US every year, cancer is the 2nd deadliest disease

Recommended screening only catches 1 in 7 cancers

Only 4 types of cancer have recommended screening options

The Cancerguard test

Helps find the deadliest cancers

Cancerguard showed a 68% sensitivity for the most deadly cancers with the lowest 5-year survival rates like pancreatic, lung, liver, esophageal, stomach, and ovarian cancers. It can offer clear, life-changing insights earlier, when treatment can make the biggest difference.

Multiple biomarker classes.
Actionable results.

The only test of its kind to combine DNA methylation and protein biomarkers

Analyzing multiple biological signals casts a wider net for detecting cancer in its early stages.

Our multi-biomarker class approach boosts detection of 6 of the deadliest cancer* organ types with the shortest 5-year survival rate.
The Cancerguard test is designed to detect more than 50 cancer types and subtypes.

Designed to minimize unnecessary follow-ups

Cancerguard was designed to streamline the diagnostic workflow after a patient receives a positive result.

Expert-designed imaging workflow

Developed by radiologists and health system experts to ease implementation

Less guesswork. Greater efficiency.

An imaging-based diagnostic workflow designed to help you provide consistent, reliable follow-up care for patients

Showed a ~30% reduction in diagnostic burden

Fewer procedures vs. molecular methods on modeling outcomes

Trusted guidance to ease patient anxiety

When patients test positive, we're here to help them. Our Positive Results Services provide patients with hands-on guidance for their next steps.

Patient Care Navigation

Our Care Navigators can act as a patient’s personal guide after a positive test result and cover things like:

Finding locations for follow-up imaging and testing
Providing eligibility details for our Patient Imaging Reimbursement Program
Help assess and reduce barriers to getting follow-up care

Imaging Reimbursement Program

Coverage of follow-up imaging after a positive result varies based on insurance plans and a patient’s unique situation. If a patient has a positive test result, our imaging reimbursement program can help reduce the financial impact for eligible patients, so they can stay focused on their health. Patients must apply and eligibility depends on program qualifications and is not guaranteed.

Results designed for clarity.

Patients results are ready about 2 weeks after our lab receives their blood sample. Results are either positive or negative and can help you determine next steps. In rare cases, an invalid result can occur.

Negative Result

A negative result means the test did not find signals of cancer.
Your patient can continue with their recommended cancer screening schedule and standard of care.

Positive Result

A positive result means the test found a signal that may indicate the presence of cancer. It’s not a cancer diagnosis.
Follow-up imaging and further evaluation are needed to locate and confirm a diagnosis, or determine that cancer is not present.

*False negative and false positive results can occur. A false negative result means the test did not find signals of cancer, but a person does have cancer. A false positive result means the test found signals of cancer, but a person doesn’t have cancer.

Get started today